CD8A and neoplasm: TNFR1, caspase-8, FADD, RIPK1, the LUBAC components, TRAF2 and cIAP1 have all been identified in genome-wide Crispr/Cas9 screens as important factors involved in the control of tumor development by CD8+ T cells and NK cells.